Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Cara-Lin Lonetree
Introduction
Cara-Lin Lonetree is a notable inventor based in Minneapolis, MN. He has made significant strides in the field of genetic engineering, particularly through his innovative patent related to lymphohematopoietic engineering.
Latest Patents
Lonetree holds a patent for "Lymphohematopoietic engineering using CAS9 base editors." This patent provides methods and systems for targeted gene disruption and targeted gene knock-in in mammalian cells. The technology utilizes base editors and guide RNAs designed to target splice acceptor-splice donor sites. Additionally, the patent includes genetically engineered cells with targeted disruptions in immunotherapy-related genes, which comprise a CAR/TCR for therapeutic applications.
Career Highlights
Lonetree is affiliated with the University of Minnesota, where he contributes to groundbreaking research in genetic engineering. His work has implications for immunotherapy and the development of advanced therapeutic techniques.
Collaborations
Some of his notable coworkers include Branden Moriarity and Beau R Webber, who collaborate with him on various research projects.
Conclusion
Cara-Lin Lonetree's contributions to genetic engineering through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact therapeutic applications in immunotherapy.